BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6232954)

  • 1. Modifications of the molecular weight of membrane-bound nonspecific beta-glucosidase in type 1 Gaucher disease determined in situ by the radiation inactivation method.
    Maret A; Potier M; Salvayre R; Douste-Blazy L
    Biochim Biophys Acta; 1984 May; 799(1):91-4. PubMed ID: 6232954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease.
    Choy FY; Woo M; Potier M
    Biochim Biophys Acta; 1986 Mar; 870(1):76-81. PubMed ID: 3947649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.
    Maret A; Potier M; Salvayre R; Douste-Blazy L
    FEBS Lett; 1983 Aug; 160(1-2):93-7. PubMed ID: 6411492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A; Carroll M
    J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro detergent activation of lysosomal acid beta-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation state.
    Maret A; Potier M; Salvayre R; Troly M; Beauregard G; Douste-Blazy L
    Biochim Biophys Acta; 1989 Jul; 996(3):254-6. PubMed ID: 2502183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
    Maret A; Salvayre R; Samadi M; Douste-Blazy L
    Enzyme; 1987; 37(4):208-17. PubMed ID: 3038513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M
    J Inherit Metab Dis; 1985; 8(1):33-7. PubMed ID: 3921758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoenzymes of membrane-bound beta-glucosidase of human spleen.
    Yaqoob M; Carroll M
    Biochem J; 1980 Feb; 185(2):541-3. PubMed ID: 6772153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-glucosidase activity in liver, spleen and brain in acute neuropathic Gaucher disease.
    Takahashi T; Nishio H; Kodama S; Nakamura H
    Brain Dev; 1990; 12(2):202-5. PubMed ID: 2113779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher's disease. I. Solubilization and electrophoresis of beta-glucosidase from leukocytes and cultured fibroblasts.
    Choy FY; Davidson RG
    Pediatr Res; 1978 Dec; 12(12):1115-20. PubMed ID: 106357
    [No Abstract]   [Full Text] [Related]  

  • 12. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M; Carroll M
    Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M; Carroll M
    Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
    [No Abstract]   [Full Text] [Related]  

  • 16. In utero diagnosis of Gaucher disease.
    Kitagawa T; Owada M; Sakiyama T; Aoki K; Kamoshita S; Amenomori Y; Kobayashi T
    Am J Hum Genet; 1978 May; 30(3):322-7. PubMed ID: 98040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative properties of the three groups of splenic beta-glucosidase molecular forms.
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Prog Clin Biol Res; 1982; 95():443-52. PubMed ID: 6812080
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of acid beta-glucosidase in a patient with Gaucher disease and leukemia.
    Leibovitz-BenGershon Z; Rosenthal J; Shinar E
    Prog Clin Biol Res; 1982; 95():481-91. PubMed ID: 6812083
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttranslational processing of human lysosomal acid beta-glucosidase: a continuum of defects in Gaucher disease type 1 and type 2 fibroblasts.
    Bergmann JE; Grabowski GA
    Am J Hum Genet; 1989 May; 44(5):741-50. PubMed ID: 2495719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of enzymes of lipid metabolism with colored and fluorescent derivatives of natural lipids.
    Gatt S; Barenholz Y; Goldberg R; Dinur T; Besley G; Leibovitz-Ben Gershon Z; Rosenthal J; Desnick RJ; Devine EA; Shafit-Zagardo B; Tsuruki F
    Methods Enzymol; 1981; 72():351-75. PubMed ID: 6273689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.